Suejin S Kim, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kim’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A95237 · Current
Licensed to practise in California · since 2006 · expires 2027-12-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$88,482
Medicare paid this office $88,482 for 430 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 110 | $25,179 | $223 |
| New patient visit (45+ min) | 107 | $15,138 | $141 |
| Biopsy of large bowel using a flexible endoscope | 126 | $9,836 | $77 |
| Short return visit (20+ min) | 89 | $7,317 | $75 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $6,886 | $92 |
See all 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 110 | $25,179 | $223 |
| New patient visit (45+ min) | 107 | $15,138 | $141 |
| Biopsy of large bowel using a flexible endoscope | 126 | $9,836 | $77 |
| Short return visit (20+ min) | 89 | $7,317 | $75 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $6,886 | $92 |
| Return visit (30+ min) | 52 | $6,030 | $110 |
| New patient visit (30+ min) | 49 | $4,744 | $97 |
| Short return visit | 32 | $1,697 | $51 |
| Diagnostic exam of anus using an endoscope | 11 | $1,377 | $125 |
| New patient visit (15+ min) | 18 | $920 | $51 |
| Injection beneath lining of large bowel using a flexible endoscope | 29 | $434 | $14 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 25 | $374 | $15 |
Procedures Medicare counted
| Colonoscopy | 104 | More than 80% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 113 | More than 79% of doctors who do this |
Who their Medicare patients are
430 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 7% · Women 67% · Also on Medicaid 9% · Health risk score 1.02. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 66% · Coronary heart disease 23% · Diabetes 22% · Cancer 21% · Depression 19% · Chronic kidney disease 15% · Atrial fibrillation 15% · COPD 10% · Heart failure 9% · Stroke 6% · Dementia 3%.
The office billed $1,021,862, Medicare allowed $117,641 and paid $88,482; for 807 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 430 | 807 | 74 | 1.02 | $1,021,862 | $88,482 |
| 2023 | 338 | 712 | 74 | 0.94 | $883,226 | $75,453 |
| 2022 | 361 | 680 | 74 | 0.95 | $853,507 | $79,504 |
| 2021 | 288 | 561 | 73 | 1.03 | $652,201 | $70,826 |
| 2020 | 188 | 448 | 74 | 1.01 | $280,856 | $42,034 |
| 2019 | 175 | 575 | 74 | 1.06 | $146,097 | $52,146 |
| 2018 | 483 | 1,278 | 72 | 1.00 | $1,107,942 | $96,958 |
| 2017 | 411 | 1,030 | 72 | 1.05 | $904,501 | $79,669 |
| 2016 | 402 | 825 | 71 | 0.96 | $808,672 | $81,277 |
| 2015 | 370 | 790 | 71 | 1.08 | $799,999 | $95,708 |
| 2014 | 372 | 791 | 71 | 1.10 | $703,281 | $81,599 |
| 2013 | 359 | 738 | 71 | 1.18 | $670,047 | $75,584 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 99 | $22,601 | $224 |
| Biopsy of large bowel using a flexible endoscope | 113 | $9,558 | $84 |
| New patient visit (45+ min) | 62 | $7,918 | $128 |
| New patient visit (30+ min) | 79 | $7,618 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 69 | $6,378 | $92 |
| Return visit (30+ min) | 46 | $5,881 | $115 |
| Short return visit (20+ min) | 60 | $5,211 | $79 |
| Telehealth originating site facility fee | 66 | $1,572 | $22 |
| Short return visit | 12 | $647 | $50 |
| Injection beneath lining of large bowel using a flexible endoscope | 23 | $346 | $15 |
2022: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 87 | $19,179 | $215 |
| New patient visit (45+ min) | 104 | $14,244 | $137 |
| Biopsy of large bowel using a flexible endoscope | 115 | $10,156 | $88 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 82 | $7,988 | $95 |
| Return visit (30+ min) | 47 | $6,512 | $118 |
| Short return visit (20+ min) | 53 | $4,982 | $79 |
| New patient visit (30+ min) | 47 | $4,008 | $85 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,208 | $201 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,768 | $161 |
| Injection beneath lining of large bowel using a flexible endoscope | 25 | $370 | $15 |
2021: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $13,564 | $215 |
| Biopsy of large bowel using a flexible endoscope | 87 | $11,682 | $133 |
| New patient visit (45+ min) | 69 | $11,068 | $160 |
| New patient visit (30+ min) | 79 | $8,463 | $107 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 71 | $6,508 | $89 |
| Short return visit (20+ min) | 43 | $4,289 | $86 |
| Return visit (30+ min) | 30 | $4,141 | $125 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,108 | $151 |
| Short return visit | 21 | $1,271 | $55 |
2020: 12 services
| New patient visit (45+ min) | 63 | $8,280 | $131 |
| Short return visit (20+ min) | 50 | $4,777 | $72 |
| New patient visit (30+ min) | 47 | $4,013 | $85 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $3,751 | $197 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,999 | $231 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,988 | $111 |
| Biopsy of large bowel using a flexible endoscope | 20 | $2,690 | $134 |
| Short return visit | 40 | $2,147 | $42 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $1,992 | $80 |
| Biopsy of large bowel using a flexible endoscope | 24 | $1,927 | $80 |
| New patient visit (15+ min) | 17 | $592 | $35 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $94 | $4 |
2019: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 45 | $10,114 | $225 |
| Biopsy of large bowel using a flexible endoscope | 72 | $8,354 | $114 |
| New patient visit (45+ min) | 44 | $6,681 | $152 |
| New patient visit (30+ min) | 67 | $6,141 | $92 |
| Short return visit (20+ min) | 49 | $5,808 | $70 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $5,699 | $90 |
| New patient visit (15+ min) | 35 | $2,101 | $60 |
| Return visit (30+ min) | 17 | $1,781 | $94 |
| Short return visit | 17 | $759 | $42 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 78 | $381 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $214 | $15 |
2018: 14 services
| Biopsy of large bowel using a flexible endoscope | 213 | $22,801 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 111 | $21,609 | $195 |
| Short return visit (20+ min) | 133 | $8,537 | $54 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $6,141 | $84 |
| New patient visit (45+ min) | 35 | $4,101 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $4,023 | $58 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 35 | $2,901 | $83 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $2,785 | $186 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,152 | $196 |
| New patient visit (30+ min) | 21 | $1,542 | $73 |
| Return visit (30+ min) | 18 | $1,338 | $74 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 277 | $1,239 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 71 | $991 | $14 |
| Short return visit | 27 | $901 | $33 |
2017: 16 services
| Biopsy of large bowel using a flexible endoscope | 195 | $21,006 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 80 | $16,658 | $208 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $5,857 | $86 |
| New patient visit (45+ min) | 46 | $5,781 | $126 |
| Short return visit (20+ min) | 79 | $4,982 | $54 |
| Return visit (30+ min) | 41 | $4,025 | $82 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $2,901 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,536 | $59 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,036 | $185 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $1,972 | $82 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,654 | $97 |
| New patient visit (30+ min) | 15 | $1,217 | $81 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 204 | $892 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 65 | $884 | $14 |
| Short return visit | 11 | $329 | $30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $171 | $8 |
2016: 15 services
| Biopsy of large bowel using a flexible endoscope | 172 | $19,478 | $111 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | $16,885 | $211 |
| Return visit (30+ min) | 64 | $5,785 | $84 |
| New patient visit (45+ min) | 37 | $4,506 | $122 |
| Short return visit (20+ min) | 72 | $4,403 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $4,385 | $58 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $4,289 | $88 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,569 | $198 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,290 | $143 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,179 | $198 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $1,878 | $82 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,829 | $96 |
| New patient visit (30+ min) | 17 | $1,414 | $83 |
| Injection beneath lining of large bowel using a flexible endoscope | 67 | $1,224 | $18 |
| Short return visit | 17 | $610 | $34 |
2015: 13 services
| Biopsy of large bowel using a flexible endoscope | 147 | $22,591 | $154 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 83 | $21,309 | $257 |
| New patient visit (45+ min) | 72 | $9,667 | $134 |
| Return visit (30+ min) | 68 | $7,175 | $84 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $5,999 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,877 | $61 |
| Short return visit (20+ min) | 49 | $3,245 | $57 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $2,977 | $198 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,912 | $224 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 33 | $2,770 | $84 |
| Imaging of digestive tract done from the inside of the digestive tract | 13 | $2,494 | $166 |
| Injection beneath lining of large bowel using a flexible endoscope | 66 | $1,619 | $25 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,536 | $90 |
2014: 15 services
| Biopsy of large bowel using a flexible endoscope | 147 | $24,163 | $161 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $11,817 | $241 |
| Short return visit (20+ min) | 97 | $6,813 | $53 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $5,600 | $89 |
| New patient visit (30+ min) | 70 | $5,398 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $5,001 | $58 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $2,761 | $162 |
| Return visit (30+ min) | 18 | $2,196 | $88 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,115 | $81 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,983 | $165 |
| New patient visit (45+ min) | 13 | $1,746 | $134 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $1,744 | $159 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,688 | $94 |
| Short return visit | 26 | $912 | $33 |
| Injection beneath lining of large bowel using a flexible endoscope | 37 | $898 | $24 |
2013: 14 services
| Biopsy of large bowel using a flexible endoscope | 139 | $21,060 | $147 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 47 | $11,121 | $237 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $6,118 | $107 |
| Short return visit (20+ min) | 89 | $5,572 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,467 | $56 |
| New patient visit (45+ min) | 29 | $3,535 | $122 |
| Return visit (30+ min) | 39 | $2,798 | $70 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $2,587 | $152 |
| New patient visit (30+ min) | 27 | $2,198 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,967 | $104 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 24 | $1,899 | $79 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,583 | $99 |
| Injection beneath lining of large bowel using a flexible endoscope | 36 | $874 | $24 |
| Short return visit | 20 | $685 | $31 |
Drugs they prescribed that Part D paid
$102,618
Pharmacies billed $102,618 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 598) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
488 generic and 110 brand-name prescriptions · $102,618 in drug cost · 18 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 13 | $34,760 | $2,674 |
| Mesalamine | 34 | $18,949 | $557 |
| Sod Sulf-Potass Sulf-Mag Sulf | 91 | $6,185 | $68 |
| Sutab | 12 | $1,954 | $163 |
| Omeprazole | 100 | $1,650 | $16 |
See all 11 drugs
| Creon | 13 | $34,760 | $2,674 |
| Mesalamine | 34 | $18,949 | $557 |
| Sod Sulf-Potass Sulf-Mag Sulf | 91 | $6,185 | $68 |
| Sutab | 12 | $1,954 | $163 |
| Omeprazole | 100 | $1,650 | $16 |
| Gavilyte-G | 87 | $1,193 | $14 |
| Pantoprazole | 50 | $860 | $17 |
| Peg-3350 and Electrolytes | 28 | $466 | $17 |
| Dicyclomine | 15 | $367 | $24 |
| Ondansetron | 19 | $259 | $14 |
| Famotidine | 22 | $192 | $9 |
Year by year
| 2024 | 598 | 303 | 0% (0) | 18% | $102,618 |
| 2023 | 502 | 261 | 0% (0) | None | $90,534 |
| 2022 | 444 | 254 | None | 36% | $53,481 |
| 2021 | 314 | 182 | None | 40% | $51,578 |
| 2020 | 209 | 121 | 0% (0) | 28% | $22,671 |
| 2019 | 268 | 193 | 0% (0) | 29% | $98,081 |
| 2018 | 515 | 263 | 0% (0) | 41% | $225,773 |
| 2017 | 506 | 208 | 0% (0) | None | $305,567 |
| 2016 | 416 | 178 | 0% (0) | None | $101,689 |
| 2015 | 361 | 136 | None | None | $87,646 |
| 2014 | 361 | 133 | None | None | $59,019 |
| 2013 | 269 | 111 | None | None | $53,025 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Vemlidy | 11 | $16,175 | $1,470 |
| Mesalamine | 25 | $15,822 | $633 |
| Sod Sulf-Potass Sulf-Mag Sulf | 65 | $4,956 | $76 |
| Sutab | 11 | $1,736 | $158 |
| Omeprazole | 100 | $1,706 | $17 |
| Gavilyte-G | 88 | $1,601 | $18 |
| Pantoprazole | 44 | $954 | $22 |
| Famotidine | 17 | $135 | $8 |
2022: 9 drugs
| Suprep | 81 | $9,162 | $113 |
| Mesalamine | 18 | $8,290 | $461 |
| Sutab | 11 | $1,708 | $155 |
| Sod Sulf-Potass Sulf-Mag Sulf | 16 | $1,361 | $85 |
| Omeprazole | 83 | $1,054 | $13 |
| Diphenoxylate-Atropine | 18 | $871 | $48 |
| Pantoprazole | 42 | $854 | $20 |
| Gavilyte-G | 43 | $745 | $17 |
| Peg-3350 and Electrolytes | 22 | $297 | $14 |
2021: 5 drugs
| Suprep | 74 | $8,097 | $109 |
| Mesalamine | 12 | $7,552 | $629 |
| Sutab | 21 | $3,204 | $153 |
| Omeprazole | 80 | $1,213 | $15 |
| Pantoprazole | 25 | $364 | $15 |
2020: 6 drugs
| Suprep | 43 | $4,500 | $105 |
| Diphenoxylate-Atropine | 11 | $642 | $58 |
| Omeprazole | 49 | $530 | $11 |
| Gavilyte-C | 20 | $312 | $16 |
| Pantoprazole | 19 | $262 | $14 |
| Famotidine | 12 | $117 | $10 |
2019: 6 drugs
| Mesalamine | 14 | $18,937 | $1,353 |
| Gavilyte-C | 74 | $2,184 | $30 |
| Suprep | 11 | $1,086 | $99 |
| Omeprazole | 42 | $801 | $19 |
| Gavilyte-G | 26 | $485 | $19 |
| Peg 3350-Electrolyte | 12 | $113 | $9 |
2018: 7 drugs
| Mesalamine | 25 | $28,448 | $1,138 |
| Apriso | 14 | $13,527 | $966 |
| Suprep | 86 | $8,096 | $94 |
| Cholestyramine | 12 | $1,814 | $151 |
| Omeprazole | 81 | $1,607 | $20 |
| Gavilyte-G | 60 | $753 | $13 |
| Peg-3350 and Electrolytes | 27 | $330 | $12 |
2017: 12 drugs
| Lialda | 28 | $41,113 | $1,468 |
| Mesalamine | 23 | $26,182 | $1,138 |
| Apriso | 16 | $9,923 | $620 |
| Carafate | 11 | $3,460 | $315 |
| Suprep | 36 | $3,166 | $88 |
| Cholestyramine | 14 | $2,354 | $168 |
| Balsalazide Disodium | 11 | $2,174 | $198 |
| Omeprazole | 80 | $1,655 | $21 |
| Moviprep | 12 | $1,115 | $93 |
| Mercaptopurine | 14 | $801 | $57 |
| Gavilyte-G | 41 | $500 | $12 |
| Peg-3350 and Electrolytes | 33 | $390 | $12 |
2016: 11 drugs
| Lialda | 20 | $30,650 | $1,532 |
| Apriso | 16 | $9,149 | $572 |
| Moviprep | 26 | $2,271 | $87 |
| Omeprazole | 70 | $1,401 | $20 |
| Mercaptopurine | 12 | $536 | $45 |
| Peg-3350 and Electrolytes | 24 | $288 | $12 |
| Gavilyte-G | 19 | $258 | $14 |
| Ondansetron | 17 | $225 | $13 |
| Prednisone | 14 | $167 | $12 |
| Spironolactone | 16 | $166 | $10 |
| Furosemide | 14 | $39 | $3 |
2015: 7 drugs
| Lialda | 34 | $35,737 | $1,051 |
| Ursodiol | 20 | $6,448 | $322 |
| Moviprep | 50 | $4,017 | $80 |
| Omeprazole | 56 | $954 | $17 |
| Diphenoxylate-Atropine | 15 | $551 | $37 |
| Peg-3350 and Electrolytes | 11 | $158 | $14 |
| Prednisone | 15 | $138 | $9 |
2014: 8 drugs
| Pentasa | 13 | $13,171 | $1,013 |
| Lialda | 16 | $12,987 | $812 |
| Moviprep | 61 | $4,869 | $80 |
| Ursodiol | 15 | $3,015 | $201 |
| Omeprazole | 62 | $1,087 | $18 |
| Diphenoxylate-Atropine | 16 | $470 | $29 |
| Peg-3350 and Electrolytes | 16 | $218 | $14 |
| Prednisone | 11 | $86 | $8 |
2013: 6 drugs
| Nexium | 12 | $5,269 | $439 |
| Asacol Hd | 11 | $4,184 | $380 |
| Moviprep | 38 | $2,765 | $73 |
| Ursodiol | 23 | $2,402 | $104 |
| Omeprazole | 63 | $1,747 | $28 |
| Pantoprazole | 14 | $270 | $19 |
Money from drug and device companies
$61,633 in 2025
| 2025 | 3 | 13 | $61,586 | $61,633 |
| 2024 | 1 | 8 | $53,374 | $53,374 |
| 2023 | 1 | 12 | $28,516 | $28,516 |
| 2022 | 1 | 9 | $20,064 | $20,064 |
| 2021 | 1 | 9 | $25,211 | $25,211 |
| 2020 | 1 | 14 | $41,976 | $41,976 |
| 2019 | 5 | 10 | None | $191 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CapsoVision | Capsocam Colon | $61,586 | 11 payments
|
| Astellas Pharma US | Vyloy | $25 | 1 payment
|
| Braintree Laboratories | Suflave | $23 | 1 payment
|
See all 13 published payments
| CapsoVision | Consulting · 2025-12-05 | Capsocam Colon | $6,901 |
| CapsoVision | Consulting · 2025-11-20 | Capsocam Colon | $3,412 |
| CapsoVision | Consulting · 2025-11-12 | Capsocam Colon | $4,312 |
| CapsoVision | Consulting · 2025-09-10 | Capsocam Colon | $3,303 |
| CapsoVision | Consulting · 2025-08-06 | Capsocam Colon | $16,837 |
| CapsoVision | Consulting · 2025-08-06 | Capsocam Colon | $5,644 |
| CapsoVision | Consulting · 2025-08-06 | Capsocam Colon | $3,499 |
| CapsoVision | Consulting · 2025-05-28 | Capsocam Colon | $4,857 |
| Braintree Laboratories | Meals · 2025-05-23 | Suflave | $23 |
| CapsoVision | Consulting · 2025-04-23 | Capsocam Colon | $8,320 |
| Astellas Pharma US | Meals · 2025-04-14 | Vyloy | $25 |
| CapsoVision | Consulting · 2025-03-06 | Capsocam Colon | $917 |
| CapsoVision | Consulting · 2025-01-08 | Capsocam Colon | $3,583 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $53,374
| CapsoVision | Capsocam Colon | $53,374 | 8 payments
|
2023: $28,516
| CapsoVision | Capsocam Colon | $28,516 | 12 payments
|
2022: $20,064
| CapsoVision | Capsocam Colon | $20,064 | 9 payments
|
2021: $25,211
| CapsoVision | Capsocam Colon | $25,211 | 9 payments
|
2020: $41,976
| CapsoVision | None | $41,976 | 14 payments
|
2019: $191
| AbbVie | Mavyret | $63 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Amitiza | $53 | 3 payments
|
| Gilead Sciences | None | $29 | 2 payments
|
| Braintree Laboratories | Motofen | $27 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $20 | 1 payment
|
Professional record
- NPI
- 1427282714
- Licence
- CA A95237California A95237: Current · expires 2027-12-31
- Trained
- University of Chicago, Pritzker School of Medicine, 2004
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2585 Samaritan Dr Fl 2, Ste 25, San Jose, CA, 95124
- NPI first listed
- 2009-05-14
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.